|
SARS coronavirus BJ182-8
|
NCBITaxon_511431 |
|
|
SARS coronavirus BJ182-4
|
NCBITaxon_511430 |
|
|
regulation of metaphase/anaphase transition of cell cycle
|
GO_1902099 |
[Any process that modulates the frequency, rate or extent of metaphase/anaphase transition of cell cycle.] |
|
regulation of sister chromatid segregation
|
GO_0033045 |
[Any process that modulates the frequency, rate or extent of sister chromatid segregation.] |
|
regulation of cell cycle phase transition
|
GO_1901987 |
[Any process that modulates the frequency, rate or extent of cell cycle phase transition.] |
|
secondary bacterial infection
|
COVID_0000011 |
|
|
secondary infection
|
IDO_0000567 |
[An infection bearing the secondary infection role.] |
|
apicidin
|
COVID_0000010 |
[Apicidin is a cyclic tetrapeptide fungal metabolite which is used as a histone deacetylase 2 (HDAC2) inhibitor.] |
|
SARS coronavirus BJ182b
|
NCBITaxon_511433 |
|
|
viral entry via permeabilization of host membrane
|
GO_0140267 |
[The entry of a virus into the cytoplasm of a host cell, triggered by an interaction between the bilayer of a host membrane and a membrane-penetration capsid protein. Results in release of the virus contents into the host cell cytoplasm.] |
|
viral entry into host cell
|
GO_0046718 |
[The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.] |
|
animal organ regeneration
|
GO_0031100 |
[The regrowth of a lost or destroyed animal organ.] |
|
regeneration
|
GO_0031099 |
[The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).] |
|
SARS coronavirus SoD
|
NCBITaxon_255194 |
|
|
cepharanthine
|
CHEBI_3546 |
[A bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation.] |
|
SARS bat coronavirus
|
NCBITaxon_1431340 |
|
|
nonpharmaceutical Intervention
|
COVID_0000019 |
|
|
intervention
|
ERO_0000347 |
[A planned process used to influence one or more factors in a research study, and the independent variable in an interventional study wherein the influence is measured or evaluated.] |
|
cytosolic ribosome
|
GO_0022626 |
[A ribosome located in the cytosol.] |
|
ribosome
|
GO_0005840 |
[An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.] |